FCC ID VN5-CN

VN5CN, VN5 CN, VN5-CN, VNS-CN

Ascensia Diabetes Care US Inc. Blood glucose monitoring system CN

An FCC ID is the product ID assigned by the FCC to identify wireless products in the market. The FCC chooses 3 or 5 character "Grantee" codes to identify the business that created the product. For example, the grantee code for FCC ID: VN5-CN is VN5. The remaining characters of the FCC ID, -CN, are often associated with the product model, but they can be random. These letters are chosen by the applicant. In addition to the application, the FCC also publishes internal images, external images, user manuals, and test results for wireless devices. They can be under the "exhibits" tab below.

Purchase on Amazon: Blood glucose monitoring system

App # Purpose Date Unique ID
1 Original Equipment 2021-06-15 4XgUxmJJLc5A2dswAm/IeQ==
2 Original Equipment 2021-06-15 s13Gp4admUS1VOC/tSruFA==

Operating Frequencies

Frequency RangePower OutputRule PartsGrant Notes App #
15BCC 1.1
2.402-2.48 GHz Bluetooth1 mW15CCC 2.1

Exhibits

Available Exhibits

App #Document Type Submitted
Available
1 FCC Test Report_15B(7901)Test Report
Adobe Acrobat PDF (230 kB)		 2021-05-25
2021-06-15
1 FCC Request for Confidentiality Letter - Contour Next GenCover Letter(s)
Adobe Acrobat PDF (92 kB)		 2021-05-24
2021-06-15
1 Internal Photos_20190625_v1 - 5_Contour Next Internal PhotosInternal Photos
Adobe Acrobat PDF (831 kB)		 2021-05-24
2021-12-12
1 FCC Test Setup photo_15B[7951]Test Setup Photos
Adobe Acrobat PDF (378 kB)		 2021-05-24
2021-12-12
1 External Photos_20190625_v1 - 4_Contour Next External PhotosExternal Photos
Adobe Acrobat PDF (547 kB)		 2021-05-24
2021-12-12
1 11_Contour Next US User ManualUsers Manual
Adobe Acrobat PDF (2646 kB)		 2021-05-24
2021-12-12
1 Cover Letters_20190625_v1 - 19_FCC Agent Auth LetterCover Letter(s)
Adobe Acrobat PDF (676 kB)		 2021-05-24
2021-06-15
1 6 7_Contour Next FCC Label and PlacementID Label/Location Info
Adobe Acrobat PDF (580 kB)		 2021-05-24
2021-06-15
2 FCC Request for Confidentiality Letter - Contour Next GenCover Letter(s)
Adobe Acrobat PDF (92 kB)		 2021-05-24
2021-06-15
2 FCC Test Report_DTS[7901]Test Report
Adobe Acrobat PDF (1063 kB)		 2021-05-24
2021-06-15
2 FCC RF Exposure[7902]RF Exposure Info
Adobe Acrobat PDF (368 kB)		 2021-05-24
2021-06-15
2 Internal Photos_20190625_v1 - 5_Contour Next Internal PhotosInternal Photos
Adobe Acrobat PDF (831 kB)		 2021-05-24
2021-12-12
2 FCC Test Setup photo_DTS[7901]Test Setup Photos
Adobe Acrobat PDF (140 kB)		 2021-05-24
2021-12-12
2 External Photos_20190625_v1 - 4_Contour Next External PhotosExternal Photos
Adobe Acrobat PDF (547 kB)		 2021-05-24
2021-12-12
2 11_Contour Next US User ManualUsers Manual
Adobe Acrobat PDF (2646 kB)		 2021-05-24
2021-12-12
2 Cover Letters_20190625_v1 - 19_FCC Agent Auth LetterCover Letter(s)
Adobe Acrobat PDF (676 kB)		 2021-05-24
2021-06-15
2 6 7_Contour Next FCC Label and PlacementID Label/Location Info
Adobe Acrobat PDF (580 kB)		 2021-05-24
2021-06-15

APP # 1 (2021-06-15)

App # Document Type Submitted
Available
1 FCC Test Report_15B(7901) Test Report
Adobe Acrobat PDF (230 kB)		 2021-05-25 00:00:00
2021-06-15 00:00:00
1 FCC Request for Confidentiality Letter - Contour Next Gen Cover Letter(s)
Adobe Acrobat PDF (92 kB)		 2021-05-24 00:00:00
2021-06-15 00:00:00
1 Internal Photos_20190625_v1 - 5_Contour Next Internal Photos Internal Photos
Adobe Acrobat PDF (831 kB)		 2021-05-24 00:00:00
2021-12-12 00:00:00
1 FCC Test Setup photo_15B[7951] Test Setup Photos
Adobe Acrobat PDF (378 kB)		 2021-05-24 00:00:00
2021-12-12 00:00:00
1 External Photos_20190625_v1 - 4_Contour Next External Photos External Photos
Adobe Acrobat PDF (547 kB)		 2021-05-24 00:00:00
2021-12-12 00:00:00
1 11_Contour Next US User Manual Users Manual
Adobe Acrobat PDF (2646 kB)		 2021-05-24 00:00:00
2021-12-12 00:00:00
1 Cover Letters_20190625_v1 - 19_FCC Agent Auth Letter Cover Letter(s)
Adobe Acrobat PDF (676 kB)		 2021-05-24 00:00:00
2021-06-15 00:00:00
1 6 7_Contour Next FCC Label and Placement ID Label/Location Info
Adobe Acrobat PDF (580 kB)		 2021-05-24 00:00:00
2021-06-15 00:00:00

APP # 2 (2021-06-15)

App # Document Type Submitted
Available
2 FCC Request for Confidentiality Letter - Contour Next Gen Cover Letter(s)
Adobe Acrobat PDF (92 kB)		 2021-05-24 00:00:00
2021-06-15 00:00:00
2 FCC Test Report_DTS[7901] Test Report
Adobe Acrobat PDF (1063 kB)		 2021-05-24 00:00:00
2021-06-15 00:00:00
2 FCC RF Exposure[7902] RF Exposure Info
Adobe Acrobat PDF (368 kB)		 2021-05-24 00:00:00
2021-06-15 00:00:00
2 Internal Photos_20190625_v1 - 5_Contour Next Internal Photos Internal Photos
Adobe Acrobat PDF (831 kB)		 2021-05-24 00:00:00
2021-12-12 00:00:00
2 FCC Test Setup photo_DTS[7901] Test Setup Photos
Adobe Acrobat PDF (140 kB)		 2021-05-24 00:00:00
2021-12-12 00:00:00
2 External Photos_20190625_v1 - 4_Contour Next External Photos External Photos
Adobe Acrobat PDF (547 kB)		 2021-05-24 00:00:00
2021-12-12 00:00:00
2 11_Contour Next US User Manual Users Manual
Adobe Acrobat PDF (2646 kB)		 2021-05-24 00:00:00
2021-12-12 00:00:00
2 Cover Letters_20190625_v1 - 19_FCC Agent Auth Letter Cover Letter(s)
Adobe Acrobat PDF (676 kB)		 2021-05-24 00:00:00
2021-06-15 00:00:00
2 6 7_Contour Next FCC Label and Placement ID Label/Location Info
Adobe Acrobat PDF (580 kB)		 2021-05-24 00:00:00
2021-06-15 00:00:00
2 Parts List & Tune Up Info._20190625_v1 - 8_Contour Next PWB Layout Schematics
Adobe Acrobat PDF (1175 kB)		 2021-05-24 00:00:00
N/A
2 Schematics_20190625_v1 - 8_Contour Next Schematic Schematics
Adobe Acrobat PDF (176 kB)		 2021-05-24 00:00:00
N/A

APP # 1 (2021-06-15)

App # Document Type Submitted
Available
1 9 10 12_Lightning Block diagram Block Diagram
Adobe Acrobat PDF (79 kB)		 2021-05-24 00:00:00
N/A

APP # 2 (2021-06-15)

App # Document Type Submitted
Available
2 9 10 12_Lightning Hardware Design Specification [2] Operational Description
Adobe Acrobat PDF (1255 kB)		 2021-05-24 00:00:00
N/A
2 MATEPD-214809-522_Lightning_Antenna_Spec Operational Description
Adobe Acrobat PDF (534 kB)		 2021-06-15 00:00:00
N/A
2 Parts List & Tune Up Info._20190625_v1 - 9_Contour Next Bill of Materials Parts List/Tune Up Info
Adobe Acrobat PDF (2069 kB)		 2021-05-24 00:00:00
N/A

APP # 1 (2021-06-15)

App # Document Type Submitted
Available
1 Lightning Block Diagram Block Diagram
Adobe Acrobat PDF (91 kB)		 2021-06-30 00:00:00
N/A

APP # 2 (2021-06-15)

App # Document Type Submitted
Available
2 TC3567AFSG-002-TDE_EN_37323 Operational Description
Adobe Acrobat PDF (2784 kB)		 2021-05-24 00:00:00
N/A
2 9 10 12_Lightning Block diagram Block Diagram
Adobe Acrobat PDF (79 kB)		 2021-05-24 00:00:00
N/A
2 Lightning Block Diagram Block Diagram
Adobe Acrobat PDF (91 kB)		 2021-06-30 00:00:00
N/A

APP # 1 (2021-06-15)

App # Document Type Submitted
Available
1 FCC Test Report_15B[7951] Test Report
Adobe Acrobat PDF (222 kB)		 2021-05-24 00:00:00
2021-06-15 00:00:00

Application Forms

Application for Equipment Authorization FCC Form 731 TCB Version


Applicant Information
Applicant's complete, legal business name: Ascensia Diabetes Care US Inc.
FCC Registration Number (FRN): 0016907776
Alphanumeric FCC ID: VN5CN
Unique Application Identifier: 4XgUxmJJLc5A2dswAm/IeQ==
Line one: 5 Wood Hollow Road
City: Parsippany
State: New Jersey
Country: United States
Zip Code: 07054

TCB Information
TCB Application Email Address: LST.FRE.CertNotice@ul.com
TCB Scope: A1: Low Power Transmitters below 1 GHz (except Spread Spectrum), Unintentional Radiators, EAS (Part 11) & Consumer ISM devices

FCC ID
Grantee Code: VN5
Product Code: -CN

Person at the applicant's address to receive grant or for contact
Name: Ben Hostetler
Title: Global Program Team - Quality Lead
Telephone Number: 574-314-9618 Extension:
Fax Number: 574-314-9618
Email: ben.hostetler@ascensia.com

Technical Contact
Firm Name:
UL LLC
First Name: Lariah
Last Name: Ijames
Line 1:
12 Laboratory Drive
City: RTP
Country:
United States
Zip Code: 27709
Telephone Number:
919-549-0945
Extension:
Fax Number: N/A
E-Mail:

Long-Term Confidentiality
Does this application include a request for confidentiality for any portion(s) of the data contained in this application pursuant to 47 CFR § 0.459 of the Commission Rules?:   Yes

Short-Term Confidentiality
Does short-term confidentiality apply to this application?:   Yes
If so, specify the short-term confidentiality release date (MM/DD/YYYY format):   12/12/2021
Note: If no date is supplied, the release date will be set to 45 calendar days past the date of grant.

Software Defined/Cognitive Radio
Is this application for software defined/cognitive radio authorization?   No

Equipment Class
Equipment Class:   JBP - Part 15 Class B Computing Device Peripheral
Description of product as it is marketed: (NOTE: This text will appear below the equipment class on the grant): Blood glucose monitoring system

Related OET KnowledgeDataBase Inquiry
Is there a KDB inquiry associated with this application?  No

Modular Equipment
Modular Type:  Does not apply

Application Purpose
Application is for:   Original Equipment

Composite/Related Equipment
Is the equipment in this application a composite device subject to an additional equipment authorization?   Yes
Is the equipment in this application part of a system that operates with, or is marketed with, another device that requires an equipment authorization?   No


Test Firm Information
Name of test firm and contact person on file with the FCC:
Firm Name:   UL Japan, Inc. Head office EMC Lab.
First Name:   Tetsuya
Last Name:   Hashimoto
Telephone Number: +81-596-24-8116 Extension:
Fax Number:  +81-596-24-8095
E-mail:  Tetsuya.Hashimoto@jp.ul.com

Grant Comments
Set the grant of this application to be deferred to a specified date:
No

Equipment Authorization Waiver
Is there an equipment authorization waiver associated with this application?  No
If there is an equipment authorization waiver associated with this application, has the associated waiver been approved and all information uploaded?:  No

WILLFUL FALSE STATEMENTS MADE ON THIS FORM ARE PUNISHABLE BY FINE AND IMPRISONMENT (U.S. CODE, TITLE 18, SECTION 1001), AND/OR REVOCATION OF ANY STATION LICENSE OR CONSTRUCTION PERMIT (U.S. CODE, TITLE 47, SECTION 312(a)(1)), AND/OR FORFEITURE (U.S. CODE, TITLE 47, SECTION 503).

SECTION 5301 (ANTI-DRUG ABUSE) CERTIFICATION:
The applicant must certify that neither the applicant nor any party to the application is subject to a denial of Federal benefits, that include FCC benefits, pursuant to Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. § 862 because of a conviction for possession or distribution of a controlled substance. See 47 CFR 1.2002(b) for the definition of a "party" for these purposes.

Does the applicant or authorized agent so certify?  Yes

Applicant/Agent Certification:

I certify that I am authorized to sign this application. All of the statements herein and the exhibits attached hereto, are true and correct to the best of my knowledge and belief. In accepting a Grant of Equipment Authorization as a result of the representations made in this application, the applicant is responsible for (1) labeling the equipment with the exact FCC ID specified in this application, (2) compliance statement labeling pursuant to the applicable rules, and (3) compliance of the equipment with the applicable technical rules. If the applicant is not the actual manufacturer of the equipment, appropriate arrangements have been made with the manufacturer to ensure that production units of this equipment will continue to comply with the FCC's technical requirements.

Authorizing an agent to sign this application, is done solely at the applicant's discretion; however, the applicant remains responsible for all statements in this application.

If an agent has signed this application on behalf of the applicant, a written letter of authorization which includes information to enable the agent to respond to the above section 5301 (Anti-Drug Abuse) Certification statement has been provided by the applicant. It is understood that the letter of authorization must be submitted to the FCC upon request, and that the FCC reserves the right to contact the applicant directly at any time.

Signature of Authorized Person Filing:  Lariah Ijames
Title of authorized signature:  Agent

Application for Equipment Authorization FCC Form 731 TCB Version


Applicant Information
Applicant's complete, legal business name: Ascensia Diabetes Care US Inc.
FCC Registration Number (FRN): 0016907776
Alphanumeric FCC ID: VN5CN
Unique Application Identifier: s13Gp4admUS1VOC/tSruFA==
Line one: 5 Wood Hollow Road
City: Parsippany
State: New Jersey
Country: United States
Zip Code: 07054

TCB Information
TCB Application Email Address: LST.FRE.CertNotice@ul.com
TCB Scope: A4: UNII devices & low power transmitters using spread spectrum techniques

FCC ID
Grantee Code: VN5
Product Code: -CN

Person at the applicant's address to receive grant or for contact
Name: Ben Hostetler
Title: Global Program Team - Quality Lead
Telephone Number: 574-314-9618 Extension:
Fax Number: 574-314-9618
Email: ben.hostetler@ascensia.com

Technical Contact
Firm Name:
UL LLC
First Name: Lariah
Last Name: Ijames
Line 1:
12 Laboratory Drive
City: RTP
Country:
United States
Zip Code: 27709
Telephone Number:
919-549-0945
Extension:
Fax Number: N/A
E-Mail:

Long-Term Confidentiality
Does this application include a request for confidentiality for any portion(s) of the data contained in this application pursuant to 47 CFR § 0.459 of the Commission Rules?:   Yes

Short-Term Confidentiality
Does short-term confidentiality apply to this application?:   Yes
If so, specify the short-term confidentiality release date (MM/DD/YYYY format):   12/12/2021
Note: If no date is supplied, the release date will be set to 45 calendar days past the date of grant.

Software Defined/Cognitive Radio
Is this application for software defined/cognitive radio authorization?   No

Equipment Class
Equipment Class:   DTS - Digital Transmission System
Description of product as it is marketed: (NOTE: This text will appear below the equipment class on the grant): Blood glucose monitoring system

Related OET KnowledgeDataBase Inquiry
Is there a KDB inquiry associated with this application?  No

Modular Equipment
Modular Type:  Does not apply

Application Purpose
Application is for:   Original Equipment

Composite/Related Equipment
Is the equipment in this application a composite device subject to an additional equipment authorization?   Yes
Is the equipment in this application part of a system that operates with, or is marketed with, another device that requires an equipment authorization?   No


Test Firm Information
Name of test firm and contact person on file with the FCC:
Firm Name:   UL Japan, Inc. Head office EMC Lab.
First Name:   Tetsuya
Last Name:   Hashimoto
Telephone Number: +81-596-24-8116 Extension:
Fax Number:  +81-596-24-8095
E-mail:  Tetsuya.Hashimoto@jp.ul.com

Grant Comments
Enter any text that you would like to appear at the bottom of the Grant of Equipment Authorization:
The output power is conducted. This device meets the SAR Test Exclusion threshold specified in KDB447498 for portable operation.
Set the grant of this application to be deferred to a specified date:
No

Equipment Authorization Waiver
Is there an equipment authorization waiver associated with this application?  No
If there is an equipment authorization waiver associated with this application, has the associated waiver been approved and all information uploaded?:  No

WILLFUL FALSE STATEMENTS MADE ON THIS FORM ARE PUNISHABLE BY FINE AND IMPRISONMENT (U.S. CODE, TITLE 18, SECTION 1001), AND/OR REVOCATION OF ANY STATION LICENSE OR CONSTRUCTION PERMIT (U.S. CODE, TITLE 47, SECTION 312(a)(1)), AND/OR FORFEITURE (U.S. CODE, TITLE 47, SECTION 503).

SECTION 5301 (ANTI-DRUG ABUSE) CERTIFICATION:
The applicant must certify that neither the applicant nor any party to the application is subject to a denial of Federal benefits, that include FCC benefits, pursuant to Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. § 862 because of a conviction for possession or distribution of a controlled substance. See 47 CFR 1.2002(b) for the definition of a "party" for these purposes.

Does the applicant or authorized agent so certify?  Yes

Applicant/Agent Certification:

I certify that I am authorized to sign this application. All of the statements herein and the exhibits attached hereto, are true and correct to the best of my knowledge and belief. In accepting a Grant of Equipment Authorization as a result of the representations made in this application, the applicant is responsible for (1) labeling the equipment with the exact FCC ID specified in this application, (2) compliance statement labeling pursuant to the applicable rules, and (3) compliance of the equipment with the applicable technical rules. If the applicant is not the actual manufacturer of the equipment, appropriate arrangements have been made with the manufacturer to ensure that production units of this equipment will continue to comply with the FCC's technical requirements.

Authorizing an agent to sign this application, is done solely at the applicant's discretion; however, the applicant remains responsible for all statements in this application.

If an agent has signed this application on behalf of the applicant, a written letter of authorization which includes information to enable the agent to respond to the above section 5301 (Anti-Drug Abuse) Certification statement has been provided by the applicant. It is understood that the letter of authorization must be submitted to the FCC upon request, and that the FCC reserves the right to contact the applicant directly at any time.

Signature of Authorized Person Filing:  Lariah Ijames
Title of authorized signature:  Agent

Applications are submitted for FCC ID and Grant requests. Click an above application to view details

Grants

TCB GRANT OF EQUIPMENT
AUTHORIZATION		 TCB
Certification
Issued Under the Authority of the
Federal Communications Commission
By:

  UL Verification Services Inc. (formerly UL CCS)
47173 Benicia Street
Fremont, CA 94538
 Date of Grant: 06/15/2021

Application Dated: 05/24/2021
Ascensia Diabetes Care US Inc.
5 Wood Hollow Road
Parsippany, NJ 07054
 
Attention: Ben Hostetler , Global Program Team - Quality Lead

NOT TRANSFERABLE
EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below.
 
FCC IDENTIFIER:  VN5-CN
Name of Grantee:  Ascensia Diabetes Care US Inc.
Equipment Class: Part 15 Class B Computing Device Peripheral
Notes: Blood glucose monitoring system
Grant Notes  FCC Rule Parts Frequency
Range (MHZ) 		Output
Watts 		Frequency
Tolerance 		Emission
Designator
CC 15B  -       


CC: This device is certified pursuant to two different Part 15 rules sections.
COPY FEDERAL COMMUNICATIONS
COMMISSION
WASHINGTON, D.C. 20554

GRANT OF EQUIPMENT
AUTHORIZATION		 COPY
Certification

Ascensia Diabetes Care US Inc.
5 Wood Hollow Road
Parsippany, NJ 07054
United States 		  Date of Grant: 06/15/2021

Application Dated: 05/24/2021
 
Attention: Ben Hostetler , Global Program Team - Quality Lead

NOT TRANSFERABLE
EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below.
 
FCC IDENTIFIER:  VN5-CN
Name of Grantee:  Ascensia Diabetes Care US Inc.
Equipment Class: Part 15 Class B Computing Device Peripheral
Notes: Blood glucose monitoring system
Modular Type: Does not apply
Grant Notes  FCC Rule Parts Frequency
Range (MHZ) 		Output
Watts 		Frequency
Tolerance 		Emission
Designator
CC 15B  -       


CC: This device is certified pursuant to two different Part 15 rules sections.

Mail To:


EA676352
TCB GRANT OF EQUIPMENT
AUTHORIZATION		 TCB
Certification
Issued Under the Authority of the
Federal Communications Commission
By:

  UL Verification Services Inc. (formerly UL CCS)
47173 Benicia Street
Fremont, CA 94538
 Date of Grant: 06/15/2021

Application Dated: 05/24/2021
Ascensia Diabetes Care US Inc.
5 Wood Hollow Road
Parsippany, NJ 07054
 
Attention: Ben Hostetler , Global Program Team - Quality Lead

NOT TRANSFERABLE
EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below.
 
FCC IDENTIFIER:  VN5-CN
Name of Grantee:  Ascensia Diabetes Care US Inc.
Equipment Class: Digital Transmission System
Notes: Blood glucose monitoring system
Grant Notes  FCC Rule Parts Frequency
Range (MHZ) 		Output
Watts 		Frequency
Tolerance 		Emission
Designator
CC 15C 2402.0  -  2480.0 0.001  

The output power is conducted. This device meets the SAR Test Exclusion threshold specified in KDB447498 for portable operation.

CC: This device is certified pursuant to two different Part 15 rules sections.
COPY FEDERAL COMMUNICATIONS
COMMISSION
WASHINGTON, D.C. 20554

GRANT OF EQUIPMENT
AUTHORIZATION		 COPY
Certification

Ascensia Diabetes Care US Inc.
5 Wood Hollow Road
Parsippany, NJ 07054
United States 		  Date of Grant: 06/15/2021

Application Dated: 05/24/2021
 
Attention: Ben Hostetler , Global Program Team - Quality Lead

NOT TRANSFERABLE
EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below.
 
FCC IDENTIFIER:  VN5-CN
Name of Grantee:  Ascensia Diabetes Care US Inc.
Equipment Class: Digital Transmission System
Notes: Blood glucose monitoring system
Modular Type: Does not apply
Grant Notes  FCC Rule Parts Frequency
Range (MHZ) 		Output
Watts 		Frequency
Tolerance 		Emission
Designator
CC 15C 2402.0  -  2480.0 0.001  

The output power is conducted. This device meets the SAR Test Exclusion threshold specified in KDB447498 for portable operation.


CC: This device is certified pursuant to two different Part 15 rules sections.

Mail To:


EA917665

Grants authorize equipment for operation at approved frequencies and sale within the USA. Click an above grant to view details